Global Nucleic Acid Blood Screening Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nucleic Acid Blood Screening competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Nucleic acid blood screening is a blood safety detection method based on molecular biology technology. Its core lies in the early diagnosis and risk elimination of viral, bacterial and other pathogen infections by specifically amplifying and detecting the nucleic acid sequences (DNA or RNA) of pathogens in blood samples. This technology uses nucleic acid amplification detection (NAT) platforms (such as real-time fluorescence quantitative PCR, transcription-mediated amplification, etc.) to identify extremely low concentrations of pathogen nucleic acids in the blood with high sensitivity and specificity. It is particularly suitable for screening samples in the "window period" of infection that cannot be covered by traditional serological tests, thereby significantly reducing the risk of transfusion-transmitted infections (TTIs) and ensuring the safety of clinical blood use. Its detection targets include blood-borne disease pathogens such as HBV, HCV, and HIV, and has become a key link in blood quality control in modern transfusion medicine.The current nucleic acid blood screening market is showing a steady growth trend worldwide. The North American market is dominant due to the popularization of nucleic acid detection technology and policy support, while the Asia-Pacific region has become the fastest growing region due to its aging population, increased medical expenditures and improved infrastructure. On the technical level, NAT (nucleic acid amplification detection) occupies the largest market share, and its high sensitivity drives the demand of end users such as blood banks and hospitals. Emerging economies such as India, the Middle East and Africa show high growth potential due to increased medical spending and disposable income, but challenges such as high technology costs and shortage of skilled personnel still restrict market development. In the future, with the iteration of testing technology and the increasing global attention to blood safety, the market is expected to usher in opportunities for continued expansion.
The global Nucleic Acid Blood Screening market size was estimated at USD 4434.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nucleic Acid Blood Screening market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nucleic Acid Blood Screening market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nucleic Acid Blood Screening market.
Global Nucleic Acid Blood Screening Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
Grifols Diagnostic Solutions
KHB
Bacme Bio
Daan Gene
Wantai Biotechnology
Sansure Biotech
Zhuhai Livzon Reagents
Bio-Rad Laboratories
Horiba
Thermo Fisher Scientific
bioMerieux
Danaher
Abbott
BD
Mindray
Market Segmentation (by Type)
Blood Screening Equipment
blood Screening Reagents
Market Segmentation (by Application)
Blood Center
Central Blood Station
Central Blood Bank
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nucleic Acid Blood Screening Market
Overview of the regional outlook of the Nucleic Acid Blood Screening Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid Blood Screening Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nucleic Acid Blood Screening, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Nucleic Acid Blood Screening market size was estimated at USD 4434.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nucleic Acid Blood Screening market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nucleic Acid Blood Screening market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nucleic Acid Blood Screening market.
Global Nucleic Acid Blood Screening Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
Grifols Diagnostic Solutions
KHB
Bacme Bio
Daan Gene
Wantai Biotechnology
Sansure Biotech
Zhuhai Livzon Reagents
Bio-Rad Laboratories
Horiba
Thermo Fisher Scientific
bioMerieux
Danaher
Abbott
BD
Mindray
Market Segmentation (by Type)
Blood Screening Equipment
blood Screening Reagents
Market Segmentation (by Application)
Blood Center
Central Blood Station
Central Blood Bank
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nucleic Acid Blood Screening Market
Overview of the regional outlook of the Nucleic Acid Blood Screening Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid Blood Screening Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nucleic Acid Blood Screening, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nucleic Acid Blood Screening
1.2 Key Market Segments
1.2.1 Nucleic Acid Blood Screening Segment by Type
1.2.2 Nucleic Acid Blood Screening Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEIC ACID BLOOD SCREENING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nucleic Acid Blood Screening Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nucleic Acid Blood Screening Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEIC ACID BLOOD SCREENING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nucleic Acid Blood Screening Product Life Cycle
3.3 Global Nucleic Acid Blood Screening Sales by Manufacturers (2020-2025)
3.4 Global Nucleic Acid Blood Screening Revenue Market Share by Manufacturers (2020-2025)
3.5 Nucleic Acid Blood Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nucleic Acid Blood Screening Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nucleic Acid Blood Screening Market Competitive Situation and Trends
3.8.1 Nucleic Acid Blood Screening Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nucleic Acid Blood Screening Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID BLOOD SCREENING INDUSTRY CHAIN ANALYSIS
4.1 Nucleic Acid Blood Screening Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEIC ACID BLOOD SCREENING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nucleic Acid Blood Screening Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nucleic Acid Blood Screening Market
5.7 ESG Ratings of Leading Companies
6 NUCLEIC ACID BLOOD SCREENING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid Blood Screening Sales Market Share by Type (2020-2025)
6.3 Global Nucleic Acid Blood Screening Market Size by Type (2020-2025)
6.4 Global Nucleic Acid Blood Screening Price by Type (2020-2025)
7 NUCLEIC ACID BLOOD SCREENING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid Blood Screening Market Sales by Application (2020-2025)
7.3 Global Nucleic Acid Blood Screening Market Size (M USD) by Application (2020-2025)
7.4 Global Nucleic Acid Blood Screening Sales Growth Rate by Application (2020-2025)
8 NUCLEIC ACID BLOOD SCREENING MARKET SALES BY REGION
8.1 Global Nucleic Acid Blood Screening Sales by Region
8.1.1 Global Nucleic Acid Blood Screening Sales by Region
8.1.2 Global Nucleic Acid Blood Screening Sales Market Share by Region
8.2 Global Nucleic Acid Blood Screening Market Size by Region
8.2.1 Global Nucleic Acid Blood Screening Market Size by Region
8.2.2 Global Nucleic Acid Blood Screening Market Size by Region
8.3 North America
8.3.1 North America Nucleic Acid Blood Screening Sales by Country
8.3.2 North America Nucleic Acid Blood Screening Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nucleic Acid Blood Screening Sales by Country
8.4.2 Europe Nucleic Acid Blood Screening Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nucleic Acid Blood Screening Sales by Region
8.5.2 Asia Pacific Nucleic Acid Blood Screening Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nucleic Acid Blood Screening Sales by Country
8.6.2 South America Nucleic Acid Blood Screening Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nucleic Acid Blood Screening Sales by Region
8.7.2 Middle East and Africa Nucleic Acid Blood Screening Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEIC ACID BLOOD SCREENING MARKET PRODUCTION BY REGION
9.1 Global Production of Nucleic Acid Blood Screening by Region(2020-2025)
9.2 Global Nucleic Acid Blood Screening Revenue Market Share by Region (2020-2025)
9.3 Global Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nucleic Acid Blood Screening Production
9.4.1 North America Nucleic Acid Blood Screening Production Growth Rate (2020-2025)
9.4.2 North America Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nucleic Acid Blood Screening Production
9.5.1 Europe Nucleic Acid Blood Screening Production Growth Rate (2020-2025)
9.5.2 Europe Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nucleic Acid Blood Screening Production (2020-2025)
9.6.1 Japan Nucleic Acid Blood Screening Production Growth Rate (2020-2025)
9.6.2 Japan Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nucleic Acid Blood Screening Production (2020-2025)
9.7.1 China Nucleic Acid Blood Screening Production Growth Rate (2020-2025)
9.7.2 China Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Basic Information
10.1.2 Roche Nucleic Acid Blood Screening Product Overview
10.1.3 Roche Nucleic Acid Blood Screening Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Grifols Diagnostic Solutions
10.2.1 Grifols Diagnostic Solutions Basic Information
10.2.2 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Overview
10.2.3 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Market Performance
10.2.4 Grifols Diagnostic Solutions Business Overview
10.2.5 Grifols Diagnostic Solutions SWOT Analysis
10.2.6 Grifols Diagnostic Solutions Recent Developments
10.3 KHB
10.3.1 KHB Basic Information
10.3.2 KHB Nucleic Acid Blood Screening Product Overview
10.3.3 KHB Nucleic Acid Blood Screening Product Market Performance
10.3.4 KHB Business Overview
10.3.5 KHB SWOT Analysis
10.3.6 KHB Recent Developments
10.4 Bacme Bio
10.4.1 Bacme Bio Basic Information
10.4.2 Bacme Bio Nucleic Acid Blood Screening Product Overview
10.4.3 Bacme Bio Nucleic Acid Blood Screening Product Market Performance
10.4.4 Bacme Bio Business Overview
10.4.5 Bacme Bio Recent Developments
10.5 Daan Gene
10.5.1 Daan Gene Basic Information
10.5.2 Daan Gene Nucleic Acid Blood Screening Product Overview
10.5.3 Daan Gene Nucleic Acid Blood Screening Product Market Performance
10.5.4 Daan Gene Business Overview
10.5.5 Daan Gene Recent Developments
10.6 Wantai Biotechnology
10.6.1 Wantai Biotechnology Basic Information
10.6.2 Wantai Biotechnology Nucleic Acid Blood Screening Product Overview
10.6.3 Wantai Biotechnology Nucleic Acid Blood Screening Product Market Performance
10.6.4 Wantai Biotechnology Business Overview
10.6.5 Wantai Biotechnology Recent Developments
10.7 Sansure Biotech
10.7.1 Sansure Biotech Basic Information
10.7.2 Sansure Biotech Nucleic Acid Blood Screening Product Overview
10.7.3 Sansure Biotech Nucleic Acid Blood Screening Product Market Performance
10.7.4 Sansure Biotech Business Overview
10.7.5 Sansure Biotech Recent Developments
10.8 Zhuhai Livzon Reagents
10.8.1 Zhuhai Livzon Reagents Basic Information
10.8.2 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Overview
10.8.3 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Market Performance
10.8.4 Zhuhai Livzon Reagents Business Overview
10.8.5 Zhuhai Livzon Reagents Recent Developments
10.9 Bio-Rad Laboratories
10.9.1 Bio-Rad Laboratories Basic Information
10.9.2 Bio-Rad Laboratories Nucleic Acid Blood Screening Product Overview
10.9.3 Bio-Rad Laboratories Nucleic Acid Blood Screening Product Market Performance
10.9.4 Bio-Rad Laboratories Business Overview
10.9.5 Bio-Rad Laboratories Recent Developments
10.10 Horiba
10.10.1 Horiba Basic Information
10.10.2 Horiba Nucleic Acid Blood Screening Product Overview
10.10.3 Horiba Nucleic Acid Blood Screening Product Market Performance
10.10.4 Horiba Business Overview
10.10.5 Horiba Recent Developments
10.11 Thermo Fisher Scientific
10.11.1 Thermo Fisher Scientific Basic Information
10.11.2 Thermo Fisher Scientific Nucleic Acid Blood Screening Product Overview
10.11.3 Thermo Fisher Scientific Nucleic Acid Blood Screening Product Market Performance
10.11.4 Thermo Fisher Scientific Business Overview
10.11.5 Thermo Fisher Scientific Recent Developments
10.12 bioMerieux
10.12.1 bioMerieux Basic Information
10.12.2 bioMerieux Nucleic Acid Blood Screening Product Overview
10.12.3 bioMerieux Nucleic Acid Blood Screening Product Market Performance
10.12.4 bioMerieux Business Overview
10.12.5 bioMerieux Recent Developments
10.13 Danaher
10.13.1 Danaher Basic Information
10.13.2 Danaher Nucleic Acid Blood Screening Product Overview
10.13.3 Danaher Nucleic Acid Blood Screening Product Market Performance
10.13.4 Danaher Business Overview
10.13.5 Danaher Recent Developments
10.14 Abbott
10.14.1 Abbott Basic Information
10.14.2 Abbott Nucleic Acid Blood Screening Product Overview
10.14.3 Abbott Nucleic Acid Blood Screening Product Market Performance
10.14.4 Abbott Business Overview
10.14.5 Abbott Recent Developments
10.15 BD
10.15.1 BD Basic Information
10.15.2 BD Nucleic Acid Blood Screening Product Overview
10.15.3 BD Nucleic Acid Blood Screening Product Market Performance
10.15.4 BD Business Overview
10.15.5 BD Recent Developments
10.16 Mindray
10.16.1 Mindray Basic Information
10.16.2 Mindray Nucleic Acid Blood Screening Product Overview
10.16.3 Mindray Nucleic Acid Blood Screening Product Market Performance
10.16.4 Mindray Business Overview
10.16.5 Mindray Recent Developments
11 NUCLEIC ACID BLOOD SCREENING MARKET FORECAST BY REGION
11.1 Global Nucleic Acid Blood Screening Market Size Forecast
11.2 Global Nucleic Acid Blood Screening Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nucleic Acid Blood Screening Market Size Forecast by Country
11.2.3 Asia Pacific Nucleic Acid Blood Screening Market Size Forecast by Region
11.2.4 South America Nucleic Acid Blood Screening Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nucleic Acid Blood Screening by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nucleic Acid Blood Screening Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nucleic Acid Blood Screening by Type (2026-2035)
12.1.2 Global Nucleic Acid Blood Screening Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nucleic Acid Blood Screening by Type (2026-2035)
12.2 Global Nucleic Acid Blood Screening Market Forecast by Application (2026-2035)
12.2.1 Global Nucleic Acid Blood Screening Sales (K Units) Forecast by Application
12.2.2 Global Nucleic Acid Blood Screening Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nucleic Acid Blood Screening
1.2 Key Market Segments
1.2.1 Nucleic Acid Blood Screening Segment by Type
1.2.2 Nucleic Acid Blood Screening Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEIC ACID BLOOD SCREENING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nucleic Acid Blood Screening Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nucleic Acid Blood Screening Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEIC ACID BLOOD SCREENING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nucleic Acid Blood Screening Product Life Cycle
3.3 Global Nucleic Acid Blood Screening Sales by Manufacturers (2020-2025)
3.4 Global Nucleic Acid Blood Screening Revenue Market Share by Manufacturers (2020-2025)
3.5 Nucleic Acid Blood Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nucleic Acid Blood Screening Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nucleic Acid Blood Screening Market Competitive Situation and Trends
3.8.1 Nucleic Acid Blood Screening Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nucleic Acid Blood Screening Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID BLOOD SCREENING INDUSTRY CHAIN ANALYSIS
4.1 Nucleic Acid Blood Screening Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEIC ACID BLOOD SCREENING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nucleic Acid Blood Screening Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nucleic Acid Blood Screening Market
5.7 ESG Ratings of Leading Companies
6 NUCLEIC ACID BLOOD SCREENING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid Blood Screening Sales Market Share by Type (2020-2025)
6.3 Global Nucleic Acid Blood Screening Market Size by Type (2020-2025)
6.4 Global Nucleic Acid Blood Screening Price by Type (2020-2025)
7 NUCLEIC ACID BLOOD SCREENING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid Blood Screening Market Sales by Application (2020-2025)
7.3 Global Nucleic Acid Blood Screening Market Size (M USD) by Application (2020-2025)
7.4 Global Nucleic Acid Blood Screening Sales Growth Rate by Application (2020-2025)
8 NUCLEIC ACID BLOOD SCREENING MARKET SALES BY REGION
8.1 Global Nucleic Acid Blood Screening Sales by Region
8.1.1 Global Nucleic Acid Blood Screening Sales by Region
8.1.2 Global Nucleic Acid Blood Screening Sales Market Share by Region
8.2 Global Nucleic Acid Blood Screening Market Size by Region
8.2.1 Global Nucleic Acid Blood Screening Market Size by Region
8.2.2 Global Nucleic Acid Blood Screening Market Size by Region
8.3 North America
8.3.1 North America Nucleic Acid Blood Screening Sales by Country
8.3.2 North America Nucleic Acid Blood Screening Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nucleic Acid Blood Screening Sales by Country
8.4.2 Europe Nucleic Acid Blood Screening Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nucleic Acid Blood Screening Sales by Region
8.5.2 Asia Pacific Nucleic Acid Blood Screening Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nucleic Acid Blood Screening Sales by Country
8.6.2 South America Nucleic Acid Blood Screening Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nucleic Acid Blood Screening Sales by Region
8.7.2 Middle East and Africa Nucleic Acid Blood Screening Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEIC ACID BLOOD SCREENING MARKET PRODUCTION BY REGION
9.1 Global Production of Nucleic Acid Blood Screening by Region(2020-2025)
9.2 Global Nucleic Acid Blood Screening Revenue Market Share by Region (2020-2025)
9.3 Global Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nucleic Acid Blood Screening Production
9.4.1 North America Nucleic Acid Blood Screening Production Growth Rate (2020-2025)
9.4.2 North America Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nucleic Acid Blood Screening Production
9.5.1 Europe Nucleic Acid Blood Screening Production Growth Rate (2020-2025)
9.5.2 Europe Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nucleic Acid Blood Screening Production (2020-2025)
9.6.1 Japan Nucleic Acid Blood Screening Production Growth Rate (2020-2025)
9.6.2 Japan Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nucleic Acid Blood Screening Production (2020-2025)
9.7.1 China Nucleic Acid Blood Screening Production Growth Rate (2020-2025)
9.7.2 China Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Basic Information
10.1.2 Roche Nucleic Acid Blood Screening Product Overview
10.1.3 Roche Nucleic Acid Blood Screening Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Grifols Diagnostic Solutions
10.2.1 Grifols Diagnostic Solutions Basic Information
10.2.2 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Overview
10.2.3 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Market Performance
10.2.4 Grifols Diagnostic Solutions Business Overview
10.2.5 Grifols Diagnostic Solutions SWOT Analysis
10.2.6 Grifols Diagnostic Solutions Recent Developments
10.3 KHB
10.3.1 KHB Basic Information
10.3.2 KHB Nucleic Acid Blood Screening Product Overview
10.3.3 KHB Nucleic Acid Blood Screening Product Market Performance
10.3.4 KHB Business Overview
10.3.5 KHB SWOT Analysis
10.3.6 KHB Recent Developments
10.4 Bacme Bio
10.4.1 Bacme Bio Basic Information
10.4.2 Bacme Bio Nucleic Acid Blood Screening Product Overview
10.4.3 Bacme Bio Nucleic Acid Blood Screening Product Market Performance
10.4.4 Bacme Bio Business Overview
10.4.5 Bacme Bio Recent Developments
10.5 Daan Gene
10.5.1 Daan Gene Basic Information
10.5.2 Daan Gene Nucleic Acid Blood Screening Product Overview
10.5.3 Daan Gene Nucleic Acid Blood Screening Product Market Performance
10.5.4 Daan Gene Business Overview
10.5.5 Daan Gene Recent Developments
10.6 Wantai Biotechnology
10.6.1 Wantai Biotechnology Basic Information
10.6.2 Wantai Biotechnology Nucleic Acid Blood Screening Product Overview
10.6.3 Wantai Biotechnology Nucleic Acid Blood Screening Product Market Performance
10.6.4 Wantai Biotechnology Business Overview
10.6.5 Wantai Biotechnology Recent Developments
10.7 Sansure Biotech
10.7.1 Sansure Biotech Basic Information
10.7.2 Sansure Biotech Nucleic Acid Blood Screening Product Overview
10.7.3 Sansure Biotech Nucleic Acid Blood Screening Product Market Performance
10.7.4 Sansure Biotech Business Overview
10.7.5 Sansure Biotech Recent Developments
10.8 Zhuhai Livzon Reagents
10.8.1 Zhuhai Livzon Reagents Basic Information
10.8.2 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Overview
10.8.3 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Market Performance
10.8.4 Zhuhai Livzon Reagents Business Overview
10.8.5 Zhuhai Livzon Reagents Recent Developments
10.9 Bio-Rad Laboratories
10.9.1 Bio-Rad Laboratories Basic Information
10.9.2 Bio-Rad Laboratories Nucleic Acid Blood Screening Product Overview
10.9.3 Bio-Rad Laboratories Nucleic Acid Blood Screening Product Market Performance
10.9.4 Bio-Rad Laboratories Business Overview
10.9.5 Bio-Rad Laboratories Recent Developments
10.10 Horiba
10.10.1 Horiba Basic Information
10.10.2 Horiba Nucleic Acid Blood Screening Product Overview
10.10.3 Horiba Nucleic Acid Blood Screening Product Market Performance
10.10.4 Horiba Business Overview
10.10.5 Horiba Recent Developments
10.11 Thermo Fisher Scientific
10.11.1 Thermo Fisher Scientific Basic Information
10.11.2 Thermo Fisher Scientific Nucleic Acid Blood Screening Product Overview
10.11.3 Thermo Fisher Scientific Nucleic Acid Blood Screening Product Market Performance
10.11.4 Thermo Fisher Scientific Business Overview
10.11.5 Thermo Fisher Scientific Recent Developments
10.12 bioMerieux
10.12.1 bioMerieux Basic Information
10.12.2 bioMerieux Nucleic Acid Blood Screening Product Overview
10.12.3 bioMerieux Nucleic Acid Blood Screening Product Market Performance
10.12.4 bioMerieux Business Overview
10.12.5 bioMerieux Recent Developments
10.13 Danaher
10.13.1 Danaher Basic Information
10.13.2 Danaher Nucleic Acid Blood Screening Product Overview
10.13.3 Danaher Nucleic Acid Blood Screening Product Market Performance
10.13.4 Danaher Business Overview
10.13.5 Danaher Recent Developments
10.14 Abbott
10.14.1 Abbott Basic Information
10.14.2 Abbott Nucleic Acid Blood Screening Product Overview
10.14.3 Abbott Nucleic Acid Blood Screening Product Market Performance
10.14.4 Abbott Business Overview
10.14.5 Abbott Recent Developments
10.15 BD
10.15.1 BD Basic Information
10.15.2 BD Nucleic Acid Blood Screening Product Overview
10.15.3 BD Nucleic Acid Blood Screening Product Market Performance
10.15.4 BD Business Overview
10.15.5 BD Recent Developments
10.16 Mindray
10.16.1 Mindray Basic Information
10.16.2 Mindray Nucleic Acid Blood Screening Product Overview
10.16.3 Mindray Nucleic Acid Blood Screening Product Market Performance
10.16.4 Mindray Business Overview
10.16.5 Mindray Recent Developments
11 NUCLEIC ACID BLOOD SCREENING MARKET FORECAST BY REGION
11.1 Global Nucleic Acid Blood Screening Market Size Forecast
11.2 Global Nucleic Acid Blood Screening Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nucleic Acid Blood Screening Market Size Forecast by Country
11.2.3 Asia Pacific Nucleic Acid Blood Screening Market Size Forecast by Region
11.2.4 South America Nucleic Acid Blood Screening Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nucleic Acid Blood Screening by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nucleic Acid Blood Screening Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nucleic Acid Blood Screening by Type (2026-2035)
12.1.2 Global Nucleic Acid Blood Screening Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nucleic Acid Blood Screening by Type (2026-2035)
12.2 Global Nucleic Acid Blood Screening Market Forecast by Application (2026-2035)
12.2.1 Global Nucleic Acid Blood Screening Sales (K Units) Forecast by Application
12.2.2 Global Nucleic Acid Blood Screening Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nucleic Acid Blood Screening Market Size by Type (M USD)
Table 4. Global Nucleic Acid Blood Screening Market Size by Application
Table 5. Nucleic Acid Blood Screening Market Size Comparison by Region (M USD)
Table 6. Global Nucleic Acid Blood Screening Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Nucleic Acid Blood Screening Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nucleic Acid Blood Screening Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nucleic Acid Blood Screening Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Blood Screening as of 2025)
Table 11. Global Market Nucleic Acid Blood Screening Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nucleic Acid Blood Screening Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nucleic Acid Blood Screening Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nucleic Acid Blood Screening Sales by Type (K Units)
Table 27. Global Nucleic Acid Blood Screening Market Size by Type (M USD)
Table 28. Global Nucleic Acid Blood Screening Sales (K Units) by Type (2020-2025)
Table 29. Global Nucleic Acid Blood Screening Sales Market Share by Type (2020-2025)
Table 30. Global Nucleic Acid Blood Screening Market Size (M USD) by Type (2020-2025)
Table 31. Global Nucleic Acid Blood Screening Market Share by Type (2020-2025)
Table 32. Global Nucleic Acid Blood Screening Price (USD/Unit) by Type (2020-2025)
Table 33. Global Nucleic Acid Blood Screening Sales (K Units) by Application
Table 34. Global Nucleic Acid Blood Screening Market Size by Application
Table 35. Global Nucleic Acid Blood Screening Sales by Application (2020-2025) & (K Units)
Table 36. Global Nucleic Acid Blood Screening Sales Market Share by Application (2020-2025)
Table 37. Global Nucleic Acid Blood Screening Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nucleic Acid Blood Screening Market Share by Application (2020-2025)
Table 39. Global Nucleic Acid Blood Screening Sales Growth Rate by Application (2020-2025)
Table 40. Global Nucleic Acid Blood Screening Sales by Region (2020-2025) & (K Units)
Table 41. Global Nucleic Acid Blood Screening Sales Market Share by Region (2020-2025)
Table 42. Global Nucleic Acid Blood Screening Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nucleic Acid Blood Screening Market Size by Region (2020-2025)
Table 44. North America Nucleic Acid Blood Screening Sales by Country (2020-2025) & (K Units)
Table 45. North America Nucleic Acid Blood Screening Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nucleic Acid Blood Screening Sales by Country (2020-2025) & (K Units)
Table 47. Europe Nucleic Acid Blood Screening Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nucleic Acid Blood Screening Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Nucleic Acid Blood Screening Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nucleic Acid Blood Screening Sales by Country (2020-2025) & (K Units)
Table 51. South America Nucleic Acid Blood Screening Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nucleic Acid Blood Screening Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Nucleic Acid Blood Screening Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nucleic Acid Blood Screening Production (K Units) by Region(2020-2025)
Table 55. Global Nucleic Acid Blood Screening Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nucleic Acid Blood Screening Revenue Market Share by Region (2020-2025)
Table 57. Global Nucleic Acid Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Nucleic Acid Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Nucleic Acid Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Nucleic Acid Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Nucleic Acid Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Roche Basic Information
Table 63. Roche Nucleic Acid Blood Screening Product Overview
Table 64. Roche Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Roche Business Overview
Table 66. Roche SWOT Analysis
Table 67. Roche Recent Developments
Table 68. Grifols Diagnostic Solutions Basic Information
Table 69. Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Overview
Table 70. Grifols Diagnostic Solutions Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Grifols Diagnostic Solutions Business Overview
Table 72. Grifols Diagnostic Solutions SWOT Analysis
Table 73. Grifols Diagnostic Solutions Recent Developments
Table 74. KHB Basic Information
Table 75. KHB Nucleic Acid Blood Screening Product Overview
Table 76. KHB Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. KHB Business Overview
Table 78. KHB SWOT Analysis
Table 79. KHB Recent Developments
Table 80. Bacme Bio Basic Information
Table 81. Bacme Bio Nucleic Acid Blood Screening Product Overview
Table 82. Bacme Bio Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bacme Bio Business Overview
Table 84. Bacme Bio Recent Developments
Table 85. Daan Gene Basic Information
Table 86. Daan Gene Nucleic Acid Blood Screening Product Overview
Table 87. Daan Gene Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Daan Gene Business Overview
Table 89. Daan Gene Recent Developments
Table 90. Wantai Biotechnology Basic Information
Table 91. Wantai Biotechnology Nucleic Acid Blood Screening Product Overview
Table 92. Wantai Biotechnology Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Wantai Biotechnology Business Overview
Table 94. Wantai Biotechnology Recent Developments
Table 95. Sansure Biotech Basic Information
Table 96. Sansure Biotech Nucleic Acid Blood Screening Product Overview
Table 97. Sansure Biotech Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Sansure Biotech Business Overview
Table 99. Sansure Biotech Recent Developments
Table 100. Zhuhai Livzon Reagents Basic Information
Table 101. Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Overview
Table 102. Zhuhai Livzon Reagents Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Zhuhai Livzon Reagents Business Overview
Table 104. Zhuhai Livzon Reagents Recent Developments
Table 105. Bio-Rad Laboratories Basic Information
Table 106. Bio-Rad Laboratories Nucleic Acid Blood Screening Product Overview
Table 107. Bio-Rad Laboratories Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Bio-Rad Laboratories Business Overview
Table 109. Bio-Rad Laboratories Recent Developments
Table 110. Horiba Basic Information
Table 111. Horiba Nucleic Acid Blood Screening Product Overview
Table 112. Horiba Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Horiba Business Overview
Table 114. Horiba Recent Developments
Table 115. Thermo Fisher Scientific Basic Information
Table 116. Thermo Fisher Scientific Nucleic Acid Blood Screening Product Overview
Table 117. Thermo Fisher Scientific Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Thermo Fisher Scientific Business Overview
Table 119. Thermo Fisher Scientific Recent Developments
Table 120. bioMerieux Basic Information
Table 121. bioMerieux Nucleic Acid Blood Screening Product Overview
Table 122. bioMerieux Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. bioMerieux Business Overview
Table 124. bioMerieux Recent Developments
Table 125. Danaher Basic Information
Table 126. Danaher Nucleic Acid Blood Screening Product Overview
Table 127. Danaher Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Danaher Business Overview
Table 129. Danaher Recent Developments
Table 130. Abbott Basic Information
Table 131. Abbott Nucleic Acid Blood Screening Product Overview
Table 132. Abbott Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Abbott Business Overview
Table 134. Abbott Recent Developments
Table 135. BD Basic Information
Table 136. BD Nucleic Acid Blood Screening Product Overview
Table 137. BD Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. BD Business Overview
Table 139. BD Recent Developments
Table 140. Mindray Basic Information
Table 141. Mindray Nucleic Acid Blood Screening Product Overview
Table 142. Mindray Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Mindray Business Overview
Table 144. Mindray Recent Developments
Table 145. Global Nucleic Acid Blood Screening Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Nucleic Acid Blood Screening Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Nucleic Acid Blood Screening Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Nucleic Acid Blood Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Nucleic Acid Blood Screening Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Nucleic Acid Blood Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Nucleic Acid Blood Screening Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Nucleic Acid Blood Screening Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Nucleic Acid Blood Screening Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Nucleic Acid Blood Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Nucleic Acid Blood Screening Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Nucleic Acid Blood Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Nucleic Acid Blood Screening Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Nucleic Acid Blood Screening Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Nucleic Acid Blood Screening Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Nucleic Acid Blood Screening Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Nucleic Acid Blood Screening Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nucleic Acid Blood Screening Market Size by Type (M USD)
Table 4. Global Nucleic Acid Blood Screening Market Size by Application
Table 5. Nucleic Acid Blood Screening Market Size Comparison by Region (M USD)
Table 6. Global Nucleic Acid Blood Screening Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Nucleic Acid Blood Screening Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nucleic Acid Blood Screening Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nucleic Acid Blood Screening Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Blood Screening as of 2025)
Table 11. Global Market Nucleic Acid Blood Screening Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nucleic Acid Blood Screening Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nucleic Acid Blood Screening Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nucleic Acid Blood Screening Sales by Type (K Units)
Table 27. Global Nucleic Acid Blood Screening Market Size by Type (M USD)
Table 28. Global Nucleic Acid Blood Screening Sales (K Units) by Type (2020-2025)
Table 29. Global Nucleic Acid Blood Screening Sales Market Share by Type (2020-2025)
Table 30. Global Nucleic Acid Blood Screening Market Size (M USD) by Type (2020-2025)
Table 31. Global Nucleic Acid Blood Screening Market Share by Type (2020-2025)
Table 32. Global Nucleic Acid Blood Screening Price (USD/Unit) by Type (2020-2025)
Table 33. Global Nucleic Acid Blood Screening Sales (K Units) by Application
Table 34. Global Nucleic Acid Blood Screening Market Size by Application
Table 35. Global Nucleic Acid Blood Screening Sales by Application (2020-2025) & (K Units)
Table 36. Global Nucleic Acid Blood Screening Sales Market Share by Application (2020-2025)
Table 37. Global Nucleic Acid Blood Screening Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nucleic Acid Blood Screening Market Share by Application (2020-2025)
Table 39. Global Nucleic Acid Blood Screening Sales Growth Rate by Application (2020-2025)
Table 40. Global Nucleic Acid Blood Screening Sales by Region (2020-2025) & (K Units)
Table 41. Global Nucleic Acid Blood Screening Sales Market Share by Region (2020-2025)
Table 42. Global Nucleic Acid Blood Screening Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nucleic Acid Blood Screening Market Size by Region (2020-2025)
Table 44. North America Nucleic Acid Blood Screening Sales by Country (2020-2025) & (K Units)
Table 45. North America Nucleic Acid Blood Screening Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nucleic Acid Blood Screening Sales by Country (2020-2025) & (K Units)
Table 47. Europe Nucleic Acid Blood Screening Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nucleic Acid Blood Screening Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Nucleic Acid Blood Screening Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nucleic Acid Blood Screening Sales by Country (2020-2025) & (K Units)
Table 51. South America Nucleic Acid Blood Screening Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nucleic Acid Blood Screening Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Nucleic Acid Blood Screening Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nucleic Acid Blood Screening Production (K Units) by Region(2020-2025)
Table 55. Global Nucleic Acid Blood Screening Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nucleic Acid Blood Screening Revenue Market Share by Region (2020-2025)
Table 57. Global Nucleic Acid Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Nucleic Acid Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Nucleic Acid Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Nucleic Acid Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Nucleic Acid Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Roche Basic Information
Table 63. Roche Nucleic Acid Blood Screening Product Overview
Table 64. Roche Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Roche Business Overview
Table 66. Roche SWOT Analysis
Table 67. Roche Recent Developments
Table 68. Grifols Diagnostic Solutions Basic Information
Table 69. Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Overview
Table 70. Grifols Diagnostic Solutions Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Grifols Diagnostic Solutions Business Overview
Table 72. Grifols Diagnostic Solutions SWOT Analysis
Table 73. Grifols Diagnostic Solutions Recent Developments
Table 74. KHB Basic Information
Table 75. KHB Nucleic Acid Blood Screening Product Overview
Table 76. KHB Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. KHB Business Overview
Table 78. KHB SWOT Analysis
Table 79. KHB Recent Developments
Table 80. Bacme Bio Basic Information
Table 81. Bacme Bio Nucleic Acid Blood Screening Product Overview
Table 82. Bacme Bio Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bacme Bio Business Overview
Table 84. Bacme Bio Recent Developments
Table 85. Daan Gene Basic Information
Table 86. Daan Gene Nucleic Acid Blood Screening Product Overview
Table 87. Daan Gene Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Daan Gene Business Overview
Table 89. Daan Gene Recent Developments
Table 90. Wantai Biotechnology Basic Information
Table 91. Wantai Biotechnology Nucleic Acid Blood Screening Product Overview
Table 92. Wantai Biotechnology Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Wantai Biotechnology Business Overview
Table 94. Wantai Biotechnology Recent Developments
Table 95. Sansure Biotech Basic Information
Table 96. Sansure Biotech Nucleic Acid Blood Screening Product Overview
Table 97. Sansure Biotech Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Sansure Biotech Business Overview
Table 99. Sansure Biotech Recent Developments
Table 100. Zhuhai Livzon Reagents Basic Information
Table 101. Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Overview
Table 102. Zhuhai Livzon Reagents Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Zhuhai Livzon Reagents Business Overview
Table 104. Zhuhai Livzon Reagents Recent Developments
Table 105. Bio-Rad Laboratories Basic Information
Table 106. Bio-Rad Laboratories Nucleic Acid Blood Screening Product Overview
Table 107. Bio-Rad Laboratories Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Bio-Rad Laboratories Business Overview
Table 109. Bio-Rad Laboratories Recent Developments
Table 110. Horiba Basic Information
Table 111. Horiba Nucleic Acid Blood Screening Product Overview
Table 112. Horiba Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Horiba Business Overview
Table 114. Horiba Recent Developments
Table 115. Thermo Fisher Scientific Basic Information
Table 116. Thermo Fisher Scientific Nucleic Acid Blood Screening Product Overview
Table 117. Thermo Fisher Scientific Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Thermo Fisher Scientific Business Overview
Table 119. Thermo Fisher Scientific Recent Developments
Table 120. bioMerieux Basic Information
Table 121. bioMerieux Nucleic Acid Blood Screening Product Overview
Table 122. bioMerieux Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. bioMerieux Business Overview
Table 124. bioMerieux Recent Developments
Table 125. Danaher Basic Information
Table 126. Danaher Nucleic Acid Blood Screening Product Overview
Table 127. Danaher Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Danaher Business Overview
Table 129. Danaher Recent Developments
Table 130. Abbott Basic Information
Table 131. Abbott Nucleic Acid Blood Screening Product Overview
Table 132. Abbott Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Abbott Business Overview
Table 134. Abbott Recent Developments
Table 135. BD Basic Information
Table 136. BD Nucleic Acid Blood Screening Product Overview
Table 137. BD Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. BD Business Overview
Table 139. BD Recent Developments
Table 140. Mindray Basic Information
Table 141. Mindray Nucleic Acid Blood Screening Product Overview
Table 142. Mindray Nucleic Acid Blood Screening Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Mindray Business Overview
Table 144. Mindray Recent Developments
Table 145. Global Nucleic Acid Blood Screening Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Nucleic Acid Blood Screening Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Nucleic Acid Blood Screening Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Nucleic Acid Blood Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Nucleic Acid Blood Screening Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Nucleic Acid Blood Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Nucleic Acid Blood Screening Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Nucleic Acid Blood Screening Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Nucleic Acid Blood Screening Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Nucleic Acid Blood Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Nucleic Acid Blood Screening Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Nucleic Acid Blood Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Nucleic Acid Blood Screening Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Nucleic Acid Blood Screening Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Nucleic Acid Blood Screening Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Nucleic Acid Blood Screening Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Nucleic Acid Blood Screening Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nucleic Acid Blood Screening
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nucleic Acid Blood Screening Market Size (M USD), 2025-2035
Figure 5. Global Nucleic Acid Blood Screening Market Size (M USD) (2020-2035)
Figure 6. Global Nucleic Acid Blood Screening Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nucleic Acid Blood Screening Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nucleic Acid Blood Screening Product Life Cycle
Figure 13. Nucleic Acid Blood Screening Sales Share by Manufacturers in 2025
Figure 14. Global Nucleic Acid Blood Screening Revenue Share by Manufacturers in 2025
Figure 15. Nucleic Acid Blood Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nucleic Acid Blood Screening Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nucleic Acid Blood Screening Revenue in 2025
Figure 18. Industry Chain Map of Nucleic Acid Blood Screening
Figure 19. Global Nucleic Acid Blood Screening Market PEST Analysis
Figure 20. Global Nucleic Acid Blood Screening Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nucleic Acid Blood Screening Market Share by Type
Figure 27. Sales Market Share of Nucleic Acid Blood Screening by Type (2020-2025)
Figure 28. Sales Market Share of Nucleic Acid Blood Screening by Type in 2025
Figure 29. Market Share of Nucleic Acid Blood Screening by Type (2020-2025)
Figure 30. Market Share of Nucleic Acid Blood Screening by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nucleic Acid Blood Screening Market Share by Application
Figure 33. Global Nucleic Acid Blood Screening Sales Market Share by Application (2020-2025)
Figure 34. Global Nucleic Acid Blood Screening Sales Market Share by Application in 2025
Figure 35. Global Nucleic Acid Blood Screening Market Share by Application (2020-2025)
Figure 36. Global Nucleic Acid Blood Screening Market Share by Application in 2025
Figure 37. Global Nucleic Acid Blood Screening Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nucleic Acid Blood Screening Sales Market Share by Region (2020-2025)
Figure 39. Global Nucleic Acid Blood Screening Market Size by Region (2020-2025)
Figure 40. North America Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nucleic Acid Blood Screening Sales Market Share by Country in 2024
Figure 43. North America Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nucleic Acid Blood Screening Market Size by Country in 2024
Figure 45. U.S. Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nucleic Acid Blood Screening Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nucleic Acid Blood Screening Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nucleic Acid Blood Screening Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nucleic Acid Blood Screening Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nucleic Acid Blood Screening Sales Market Share by Country in 2024
Figure 53. Europe Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nucleic Acid Blood Screening Market Size by Country in 2024
Figure 55. Germany Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nucleic Acid Blood Screening Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nucleic Acid Blood Screening Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nucleic Acid Blood Screening Market Size by Region in 2024
Figure 68. China Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nucleic Acid Blood Screening Sales and Growth Rate (K Units)
Figure 79. South America Nucleic Acid Blood Screening Sales Market Share by Country in 2024
Figure 80. South America Nucleic Acid Blood Screening Market Size and Growth Rate (M USD)
Figure 81. South America Nucleic Acid Blood Screening Market Size by Country in 2024
Figure 82. Brazil Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nucleic Acid Blood Screening Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nucleic Acid Blood Screening Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nucleic Acid Blood Screening Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nucleic Acid Blood Screening Market Size by Region in 2024
Figure 92. Saudi Arabia Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nucleic Acid Blood Screening Production Market Share by Region (2020-2025)
Figure 103. North America Nucleic Acid Blood Screening Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nucleic Acid Blood Screening Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nucleic Acid Blood Screening Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nucleic Acid Blood Screening Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nucleic Acid Blood Screening Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Nucleic Acid Blood Screening Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nucleic Acid Blood Screening Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nucleic Acid Blood Screening Market Share Forecast by Type (2026-2035)
Figure 111. Global Nucleic Acid Blood Screening Sales Forecast by Application (2026-2035)
Figure 112. Global Nucleic Acid Blood Screening Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Nucleic Acid Blood Screening
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nucleic Acid Blood Screening Market Size (M USD), 2025-2035
Figure 5. Global Nucleic Acid Blood Screening Market Size (M USD) (2020-2035)
Figure 6. Global Nucleic Acid Blood Screening Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nucleic Acid Blood Screening Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nucleic Acid Blood Screening Product Life Cycle
Figure 13. Nucleic Acid Blood Screening Sales Share by Manufacturers in 2025
Figure 14. Global Nucleic Acid Blood Screening Revenue Share by Manufacturers in 2025
Figure 15. Nucleic Acid Blood Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nucleic Acid Blood Screening Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nucleic Acid Blood Screening Revenue in 2025
Figure 18. Industry Chain Map of Nucleic Acid Blood Screening
Figure 19. Global Nucleic Acid Blood Screening Market PEST Analysis
Figure 20. Global Nucleic Acid Blood Screening Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nucleic Acid Blood Screening Market Share by Type
Figure 27. Sales Market Share of Nucleic Acid Blood Screening by Type (2020-2025)
Figure 28. Sales Market Share of Nucleic Acid Blood Screening by Type in 2025
Figure 29. Market Share of Nucleic Acid Blood Screening by Type (2020-2025)
Figure 30. Market Share of Nucleic Acid Blood Screening by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nucleic Acid Blood Screening Market Share by Application
Figure 33. Global Nucleic Acid Blood Screening Sales Market Share by Application (2020-2025)
Figure 34. Global Nucleic Acid Blood Screening Sales Market Share by Application in 2025
Figure 35. Global Nucleic Acid Blood Screening Market Share by Application (2020-2025)
Figure 36. Global Nucleic Acid Blood Screening Market Share by Application in 2025
Figure 37. Global Nucleic Acid Blood Screening Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nucleic Acid Blood Screening Sales Market Share by Region (2020-2025)
Figure 39. Global Nucleic Acid Blood Screening Market Size by Region (2020-2025)
Figure 40. North America Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nucleic Acid Blood Screening Sales Market Share by Country in 2024
Figure 43. North America Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nucleic Acid Blood Screening Market Size by Country in 2024
Figure 45. U.S. Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nucleic Acid Blood Screening Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nucleic Acid Blood Screening Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nucleic Acid Blood Screening Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nucleic Acid Blood Screening Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nucleic Acid Blood Screening Sales Market Share by Country in 2024
Figure 53. Europe Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nucleic Acid Blood Screening Market Size by Country in 2024
Figure 55. Germany Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nucleic Acid Blood Screening Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nucleic Acid Blood Screening Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nucleic Acid Blood Screening Market Size by Region in 2024
Figure 68. China Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nucleic Acid Blood Screening Sales and Growth Rate (K Units)
Figure 79. South America Nucleic Acid Blood Screening Sales Market Share by Country in 2024
Figure 80. South America Nucleic Acid Blood Screening Market Size and Growth Rate (M USD)
Figure 81. South America Nucleic Acid Blood Screening Market Size by Country in 2024
Figure 82. Brazil Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nucleic Acid Blood Screening Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nucleic Acid Blood Screening Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nucleic Acid Blood Screening Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nucleic Acid Blood Screening Market Size by Region in 2024
Figure 92. Saudi Arabia Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nucleic Acid Blood Screening Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nucleic Acid Blood Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nucleic Acid Blood Screening Production Market Share by Region (2020-2025)
Figure 103. North America Nucleic Acid Blood Screening Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nucleic Acid Blood Screening Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nucleic Acid Blood Screening Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nucleic Acid Blood Screening Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nucleic Acid Blood Screening Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Nucleic Acid Blood Screening Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nucleic Acid Blood Screening Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nucleic Acid Blood Screening Market Share Forecast by Type (2026-2035)
Figure 111. Global Nucleic Acid Blood Screening Sales Forecast by Application (2026-2035)
Figure 112. Global Nucleic Acid Blood Screening Market Share Forecast by Application (2026-2035)
